Heart pump trial aims to rescue patients from severe shock
NCT ID NCT06965504
Summary
This study is testing if using a temporary heart pump (Impella 5.5) can help doctors safely start and increase the doses of four key heart failure medications in patients who are critically ill with heart failure shock. The goal is to see if this combined approach helps the heart recover during the hospital stay and for up to a year after discharge. The study will include about 60 adults with weakened heart function who are not yet on the full recommended medication regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Abbott Northwestern
Minneapolis, Minnesota, 555407, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centennial Medical Center
Nashville, Tennessee, 32703, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tampa General Hospital
Tampa, Florida, 33606, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Pennsylvania Health System
Philadelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.